Results 131 to 140 of about 3,001,389 (308)
Traffic Engineering in Multiprotocol Label Switching networks
Chung-Yu Wei
openalex +2 more sources
Performance Evaluation of Multi-Layer Traffic Engineering Enabled IP-over-ION Networks [PDF]
Qiang Yan+6 more
openalex +1 more source
This study reveals a novel mechanistic connection between cancer and ischemia/reperfusion (I/R)‐induced cardiac injury. The meta‐analysis demonstrates significantly higher incidence ratios of both all‐cause mortality and cardiovascular mortality in cancer patients undergoing percutaneous coronary intervention (PCI) compared to non‐cancer patients.
Zhongting Mei+14 more
wiley +1 more source
Traffic engineering for MPLS-based virtual private networks
Chun Tung Chou
openalex +2 more sources
Traffic engineering of management flows by link augmentations on confluent trees [PDF]
Randeep Bhatia+5 more
openalex +1 more source
This work reports a mitochondria‐targeted nanozyme platform, MIL‐Cu1.8S‐TPP/FA, which induces potent cuproptosis via localized delivery of Cu1.8S nanodots to mitochondria. Surface‐anchoring these nanodots onto MIL‐88B metal‐organic frameworks enhances both passive and active tumor targeting.
Chenguang Liu+8 more
wiley +1 more source
The TALENTs randomized controlled trial evaluates the potential of nucleotides supplementation as an anti‐aging intervention in older adults. After 19 weeks, nucleotides supplementation significantly reduces DNA methylation age, suggesting a delay in epigenetic aging, and improves insulin sensitivity without severe adverse events.
Shuyue Wang+9 more
wiley +1 more source
Assessment of the stopping for right-turning large vehicles policy in Nanjing: Effectiveness and determinants. [PDF]
Zhu Y.
europepmc +1 more source
Traffic Engineering Using OSPF Weights and Splitting Ratios
John Murphy+2 more
openalex +1 more source
Tunneling nanotubes facilitate the transfer of long‐chain fatty acids, primarily arachidonic acid, from tumor cells to macrophages, leading to lipid accumulation and activation of the PI3K‐Akt pathway. This drives a shift from the anti‐tumor CD5L⁺ phenotype to a pro‐tumor TREM2⁺ phenotype.
Meiru Chen+7 more
wiley +1 more source